Fully grown mammalian oocytes maintain a prophase I germinalvesicle stage arrest in the ovary for extended periods before a luteinizing hormone surge induces entry into the first meiotic division. Cdh1 is an activator of the anaphase-promoting complex (APC) and APC cdh1 is normally restricted to late M to early G1 phases of the cell cycle. Here, we find that APC cdh1 is active in mouse oocytes and is necessary to maintain prophase arrest.
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Fully grown mammalian oocytes remain arrested at prophase I within antral follicles until stimulated to enter the first meiotic division by a midcycle surge in luteinizing hormone. An oolemma (the plasma membrane of the oocyte) receptor maintains this arrest by increasing protein kinase A activity 1 which inhibits maturation-promoting factor (MPF; comprised of CDK1 and cyclin B1) by affecting the phosphorylation status of CDK1 (ref. 2) . Oocytes can resume meiosis spontaneously (manifested by germinal-vesicle breakdown; GVB) when released into culture media, but remain arrested if agents such as the phosphodiesterase inhibitor milrinone 3 , are added to maintain protein kinase A activity. Raising cyclin B1 levels in milrinone-arrested oocytes by microinjection of its cRNA coupled to GFP induced GVB. The spatial distribution of cyclin B1-GFP expressed in oocytes mirrored that reported in adult cells 4 (see Supplementary Information, Fig. S1a ). Cytoplasmic cyclin B1 entered the nucleus before GVB and became associated with chromatin afterwards. However, the rate of GVB in these oocytes was <15% by 5 h (Fig. 1a) , and never exceeded 20%, even after 24 h. The proteasomal inhibitor, MG132, had a mild stimulatory effect on GVB over 5 h of treatment, and when combined with cyclin B1 the rate of GVB increased 2-3-fold compared with cyclin B1 alone ( Fig. 1a and see Supplementary Information, Table S1 ). It is likely that the increased rate of GVB was caused by increased cyclin B1-GFP, as levels doubled with MG132 treatment (Fig. 1b) .
Cyclin B1 degradation requires polyubiquitination by the APC followed by proteasomal degradation 5 . During mitosis, the APC needs one of two essential co-activators, cdc20 or cdh1, which are both present in mouse eggs 6 . APC cdc20 and APC cdh1 both degrade substrates (such as cyclin B1) that contain a destruction (D)-box motif. Therefore, the previously described cyclin B1 experiment was repeated using cyclin B1 Δ90 , 1 Institute for Cell and Molecular Biosciences, The Medical School, Framlington Place, University of Newcastle-upon-Tyne, Newcastle, NE2 4HH, UK. 2 These authors contributed equally to this work. . Cyclin B1 Δ90 cRNA induced 70% GVB rates by 5 h (Fig. 1a) and 80% by 24 h. These rates that are 4-5-fold higher than cyclin B1-GFP and, together with the MG132 data, are consistent with cyclin B1 being degraded in germinal-vesicle oocytes.
Cyclin B1 degradation in oocytes, where MPF is low, is likely to be due to APC cdh1 as APC cdc20 requires high levels of MPF for its activity 8 . Oocytes do contain cdh1 (see Supplementary Information, Fig. S1b ), therefore to examine whether APC cdh1 was active at this time , two further APC cdh1 substrates (in addition to cyclin B1) were coupled to GFP, their cRNA injected into oocytes and their stability measured following inhibition of protein synthesis. The substrates used were cdc20 and a mutant form of securin (securin , by virtue of a KEN-box (Lys−Glu−Asn) 7, 9 . All three APC cdh1 substrates, but not a GFP control, were degraded ( Fig. 1c and see Supplementary Information, Table S1 ). Degradation of endogenous cyclin B1 was also observed during the same time period, suggesting the degradation of the APC cdh1 substrates is not an artefact of very high protein levels (see Supplementary Information, Fig. S1e ). Consistent with destruction of these proteins through the action of a ubiquitin ligase, cdc20-GFP loss was blocked by methylubiquitin (which terminates polyubiquitination) and MG132 (see Supplementary Information, Table S1 ).
To exclude cdh1-independent mechanisms for degradation, the ability of these substrates to be degraded in oocytes knocked-down for cdh1 was examined. Microinjection of a cdh1 morpholino oligonucleotide (cdh1 MO) for 24 h reduced cdh1 levels by approximately 90% (see Supplementary Information, Fig. S1c ) and inhibited degradation of the APC cdh1 substrates (Fig. 1c and see Supplementary Information, Table S1 ). The specificity of these observations to cdh1 knockdown was confirmed by two approaches. First, it was observed that cyclin B1-GFP degradation proceeded normally in oocytes incubated for 24 h with a control morpholino oligonucleotide (cdh1 inv MO) that is an inverted base sequence of the cdh1 MO (see Supplementary Information, Fig. S1f and Table S1 ). Second, a cdh1 rescue experiment was performed (see Supplementary  Information, Fig. S1d ) and the degradation of these APC cdh1 substrates was observed following addition of cdh1 cRNA to cdh1 MO-treated oocytes (Fig. 1c and see Supplementary Information, Table S1 ).
We wanted to establish whether the measurable APC cdh1 activity in germinal-vesicle oocytes had any physiological role in the process of germinal-vesicle arrest, especially as it could degrade cyclin B1. In noninjected oocytes, 2.5% of oocytes underwent GVB at 24 h and 5% at 48 h (Fig. 2) . Similarly low levels of GVB also occurred in oocytes microinjected with the control cdh1 inv MO over 48 h, demonstrating that milrinone provides a very good block to GVB. However, cdh1 MO induced GVB with approximately 30% of oocytes undergoing GVB at 24 h and approximately 60% at 48 h -an effect that was reversed by cdh1 rescue. Furthermore, cdh1 MO dramatically increased the rate of GVB achieved by microinjection of cyclin B1 cRNA (Fig. 2a) . Finally, increased endogenous cyclin B1 levels were also observed following introduction of cdh1 MO, but not cdh1 inv MO, in both oocytes that had remained germinalvesicle arrested or had undergone GVB, although as expected cyclin B1 was higher for the latter (see Supplementary Information, Fig. S1e) .
We have described an essential role for APC cdh1 in maintaining arrest in prophase I oocytes. Although APC cdh1 is a ubiquitin ligase associated with late M to early G1 phases of the mitotic cell cycle, our findings are not without precedence as APC cdh1 also functions in the axonal morphogenesis of post-mitotic brain neurones 10 . Taken together, these observations suggest that APC cdh1 has been adapted to specialised cell functions outside of mitotic exit. 
